
Chemfab Alkalis (CHEMFAB) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
915.4M
Gross Profit
313.1M
34.21%
Operating Income
49.1M
5.36%
Net Income
25.5M
2.78%
EPS (Diluted)
₹1.77
Balance Sheet Metrics
Total Assets
5.2B
Total Liabilities
1.4B
Shareholders Equity
3.8B
Debt to Equity
0.37
Cash Flow Metrics
Revenue & Profitability Trend
Chemfab Alkalis Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 3.3B | 3.3B | 3.3B | 2.7B | 1.8B |
Cost of Goods Sold | 2.2B | 2.2B | 1.7B | 1.7B | 1.2B |
Gross Profit | 1.2B | 1.1B | 1.6B | 972.6M | 604.6M |
Gross Margin % | 34.7% | 32.5% | 47.3% | 35.9% | 33.5% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 114.3M | 79.2M | 39.2M | 50.2M |
Other Operating Expenses | 466.9M | 123.1M | 126.2M | 116.3M | 128.3M |
Total Operating Expenses | 466.9M | 237.4M | 205.4M | 155.5M | 178.5M |
Operating Income | 73.9M | 322.5M | 879.9M | 357.9M | 38.5M |
Operating Margin % | 2.2% | 9.9% | 26.6% | 13.2% | 2.1% |
Non-Operating Items | |||||
Interest Income | - | 20.7M | 6.2M | 17.2M | 4.3M |
Interest Expense | 49.2M | 9.4M | 2.4M | 10.1M | 24.5M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -3.1M | 391.5M | 894.4M | 391.0M | 20.3M |
Income Tax | 66.3M | 128.2M | 248.6M | 103.6M | 101.6M |
Effective Tax Rate % | 0.0% | 32.8% | 27.8% | 26.5% | 501.4% |
Net Income | -69.4M | 263.2M | 645.8M | 287.5M | -81.3M |
Net Margin % | -2.1% | 8.0% | 19.5% | 10.6% | -4.5% |
Key Metrics | |||||
EBITDA | 508.4M | 590.7M | 1.1B | 628.2M | 244.2M |
EPS (Basic) | ₹-4.86 | ₹18.53 | ₹45.61 | ₹20.36 | ₹-5.81 |
EPS (Diluted) | ₹-4.86 | ₹18.34 | ₹45.14 | ₹20.20 | ₹-5.81 |
Basic Shares Outstanding | 14280453 | 14209147 | 14160974 | 14122397 | 14007448 |
Diluted Shares Outstanding | 14280453 | 14209147 | 14160974 | 14122397 | 14007448 |
Income Statement Trend
Chemfab Alkalis Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 47.0M | 23.4M | 9.8M | 22.1M | 178.0K |
Short-term Investments | 170.4M | 53.6M | 682.3M | 306.3M | 239.4M |
Accounts Receivable | 207.7M | 212.2M | 217.3M | 214.4M | 151.6M |
Inventory | 271.8M | 160.1M | 169.4M | 118.4M | 92.9M |
Other Current Assets | 264.7M | 267.5M | - | 99.6M | 90.7M |
Total Current Assets | 1.2B | 1.0B | 1.2B | 922.8M | 756.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 3.2B | 15.6M | 15.6M | 14.9M | 3.5M |
Goodwill | 368.0K | 555.0K | 425.0K | 934.0K | 1.5M |
Intangible Assets | - | 555.0K | 425.0K | 934.0K | 1.5M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 215.8M | 489.6M | - | -20.0K | 80.8M |
Total Non-Current Assets | 4.0B | 4.0B | 2.9B | 2.6B | 2.6B |
Total Assets | 5.2B | 5.0B | 4.1B | 3.5B | 3.3B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 322.5M | 272.6M | 276.9M | 202.0M | 181.6M |
Short-term Debt | 191.3M | 22.4M | 4.5M | 71.3M | 77.3M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 136.2M | 34.3M | 32.7M | 34.7M | 25.6M |
Total Current Liabilities | 722.0M | 918.6M | 459.0M | 507.1M | 414.5M |
Non-Current Liabilities | |||||
Long-term Debt | 652.1M | 178.7M | 19.1M | 15.2M | 238.1M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 12.0M | -1.0K | - | 11.5M | 11.5M |
Total Non-Current Liabilities | 696.4M | 212.0M | 48.4M | 34.7M | 261.4M |
Total Liabilities | 1.4B | 1.1B | 507.4M | 541.8M | 676.0M |
Equity | |||||
Common Stock | 143.6M | 142.3M | 141.8M | 141.3M | 140.6M |
Retained Earnings | - | 115.0M | -132.1M | -753.6M | -1.0B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 3.8B | 3.9B | 3.6B | 3.0B | 2.7B |
Key Metrics | |||||
Total Debt | 843.4M | 201.1M | 23.6M | 86.5M | 315.5M |
Working Capital | 471.7M | 87.2M | 785.3M | 415.7M | 342.1M |
Balance Sheet Composition
Chemfab Alkalis Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -3.1M | 263.2M | 645.8M | 287.5M | -81.3M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | 3.8M | 6.1M | 8.4M | 5.1M |
Working Capital Changes | 0 | -218.2M | -49.4M | -102.7M | 1.0M |
Operating Cash Flow | -3.1M | 28.0M | 601.9M | 187.7M | -57.0M |
Investing Activities | |||||
Capital Expenditures | - | -915.1M | -526.5M | -195.7M | -71.6M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | - | -915.1M | -526.5M | -195.7M | -70.2M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | -17.7M | -17.7M | -176.0K | -17.2M |
Debt Issuance | - | 185.0M | 0 | - | - |
Debt Repayment | - | -3.0M | 0 | -218.6M | -62.4M |
Financing Cash Flow | - | 171.7M | -81.0M | -233.5M | -126.9M |
Free Cash Flow | 399.1M | -605.7M | 349.8M | 347.1M | 381.0M |
Net Change in Cash | -3.1M | -715.4M | -5.6M | -241.5M | -254.1M |
Cash Flow Trend
Chemfab Alkalis Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
160.23
Price to Book
2.58
Price to Sales
2.81
PEG Ratio
0.89
Profitability Ratios
Profit Margin
-1.51%
Operating Margin
5.36%
Return on Equity
-1.83%
Return on Assets
-1.33%
Financial Health
Current Ratio
1.65
Debt to Equity
22.20
Beta
-0.61
Per Share Data
EPS (TTM)
₹-3.69
Book Value per Share
₹264.55
Revenue per Share
₹243.91
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
chemfab | 9.8B | 160.23 | 2.58 | -1.83% | -1.51% | 22.20 |
Asian Paints | 2.4T | 67.58 | 12.50 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.94 | 16.09 | 20.85% | 16.16% | 4.56 |
Balaji Amines | 50.2B | 33.00 | 2.72 | 7.80% | 11.11% | 0.55 |
Kingfa Science | 46.2B | 30.12 | 6.35 | 20.98% | 8.58% | 5.90 |
Grauer & Weil | 42.1B | 26.73 | 4.48 | 16.73% | 13.35% | 1.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.